Literature DB >> 26011486

Gynaecological cancer: Biomarker potential of CA-125 enhanced.

David Killock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26011486     DOI: 10.1038/nrclinonc.2015.95

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

Authors:  Usha Menon; Andy Ryan; Jatinderpal Kalsi; Aleksandra Gentry-Maharaj; Anne Dawnay; Mariam Habib; Sophia Apostolidou; Naveena Singh; Elizabeth Benjamin; Matthew Burnell; Susan Davies; Aarti Sharma; Richard Gunu; Keith Godfrey; Alberto Lopes; David Oram; Jonathan Herod; Karin Williamson; Mourad W Seif; Howard Jenkins; Tim Mould; Robert Woolas; John B Murdoch; Stephen Dobbs; Nazar N Amso; Simon Leeson; Derek Cruickshank; Ian Scott; Lesley Fallowfield; Martin Widschwendter; Karina Reynolds; Alistair McGuire; Stuart Campbell; Mahesh Parmar; Steven J Skates; Ian Jacobs
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

  1 in total
  1 in total

Review 1.  Emerging role of m6A methylation modification in ovarian cancer.

Authors:  Lin-Lin Chang; Xia-Qing Xu; Xue-Ling Liu; Qian-Qian Guo; Yan-Nan Fan; Bao-Xia He; Wen-Zhou Zhang
Journal:  Cancer Cell Int       Date:  2021-12-11       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.